Research overview
About Retatrutide
Retatrutide is an investigational peptide designed to activate GIP, GLP-1, and glucagon receptors. Published clinical research has focused on its pharmacology and effects within metabolic signaling systems.
Research use only
Receptor-signaling research
Retatrutide
10 mg
Choose strength
$119.99
An investigational triple-receptor agonist studied across GIP, GLP-1, and glucagon signaling pathways.
Laboratory research only
Research context included
For laboratory research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease.
Areas of investigation
GIP receptor signaling
GLP-1 receptor signaling
Glucagon receptor signaling
Metabolic pathway research
Scholarly references